ORIC-533

· ORIC Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ORIC-533, covering 2025-03-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma [Phase 1]